fbpx
Donate Toggle Menu

Belzutifan results “practice changing” at ESMO 2023

Three analyses of the LITESPARK trial examining the hypoxia-inducible factor 2a (HIF-2a) belzutifan (Welireg) showed efficacy and benefit for this novel therapy over comparator treatments in advanced clear cell renal cell carcinoma (RCC) as well…

Lindsay Walker’s Halloween became scarier than she intended

This is a guest post by Lindsay Walker. Lindsay, 46, was diagnosed with stage 3 chromophobe renal cell carcinoma in November 2022, right after Halloween. My kidney cancer journey began on Halloween 2022. I never…

Exercise and Sickle Cell Trait: New research unveils the connection

The KCA recently partnered with two advocacy groups on a blog post examining the relationship between exercise and sickle cell trait. This blog post appears at Sick Cells, a national non-profit advocacy group for sickle…

Q&A: Dr. Brendon Guercio, Interdisciplinary RCC Focus Award winner

Dr. Brendan Guercio received a 2023 Interdisciplinary RCC Focus Award for research on “Associations of diet with the gut microbiome among patients with advanced/metastatic RCC receiving immune checkpoint inhibition.” This award was supported by a…

Q&A: Dr. Niki Zacharias Millward, Chromophobe RCC Focus Award winner

Dr. Niki Zacharias Millward, PhD,  received a 2023 KCA Chromophobe RCC Focus Award for research on “Leveraging patient-derived xenograft models to identify and therapeutically target metabolic hallmarks of chromophobe renal cell carcinoma.” Dr. Millward is…

Q&A: Dr. Shinji Ohtake, Unclassified/Papillary RCC Focus Award winner

Dr. Shinji Ohtake received a 2023 Unclassified/Papillary RCC Focus Award for research on the “Development of Models of NF2 loss in papillary and unclassified variant of kidney cancer.” This award was supported by a gift…

Q&A: Dr. Prateek Khanna, Translocation RCC Focus Award winner

Dr. Prateek Khanna received a 2023 KCA Translocation RCC Focus Award for research on “Therapeutic targeting of cell surface antigens in translocation renal cell carcinoma.” This award was given in partnership with Joey’s Wings Foundation,…

Q&A: Dr. Rana McKay, KCA Trailblazer Award winner

Dr. Rana McKay received a 2023 KCA Trailblazer Award for research on “Dissecting predictors of response to immunotherapy in patients with renal cell carcinoma.” Dr. McKay is a medical oncologist at UC San Diego Health…

Q&A: Dr. Maria Carlo, KCA Trailblazer Award winner

Dr. Maria Carlo received a 2023 KCA Trailblazer Award for research on the “Role of germline and somatic variants in NRF2 pathway genes in renal cell carcinoma.” Dr. Carlo is a genitourinary oncologist and clinical…

Q&A: Follow-Up From the 2023 Virtual Patient Symposium

The KCA’s 2023 Virtual Patient Symposium took place on September 9th with expert speakers presenting topics ranging from kidney cancer basics and breaking new research to discussions about nutrition, psychosocial support, and the patient experience….

1 3 4 5 6 7 31